Annual report
2425.TEDINET S100W0LY
Period2024-04-01 → 2025-03-31
Filed2025-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥9.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥9.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥9.2bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.0bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥521m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥518m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥581m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥557m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥476m | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥327m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥320m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥553m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥538m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥374m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥378m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥324m | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥192m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥191m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥374m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥378m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥4.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥3.9bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥3.5bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.2bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.2bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.2bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.2bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.9bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.6bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.3bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.9bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.8bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥930m | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥969m | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥554m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥546m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥443m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥338m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥341m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥143m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥102m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥36m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥184m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥49m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥92m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥120m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥152m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥192m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥275m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥98.6 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥99.56 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.36 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.66 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.29 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥770.7 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥696.69 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥610.61 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥532.03 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥489.58 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 71.0% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.5% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.0% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.3% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.7% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 13.4% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.2% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.9% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.9% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.7% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,040 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 1,073 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 1,039 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 1,014 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 998 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥9.8bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥9.6bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥9.2bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥8.9bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥8.6bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥534m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥510m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥559m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥564m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥509m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥350m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥358m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥487m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥539m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥309m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥379m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥357m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥184m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥183m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥4.1bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥3.9bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥3.5bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.2bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.2bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.2bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.2bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.9bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.7bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.3bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥2.0bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.9bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.8bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥81.35 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥99.92 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.23 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.61 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.14 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥20 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥8.5 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥768.41 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥703.06 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥617.14 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥532.91 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥492.8 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 70.9% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.7% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.3% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.4% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.9% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 11.1% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.1% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.4% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.5% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.2% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 4,200,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,200,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,200,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,200,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,200,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,040 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 1,063 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 1,024 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 998 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 974 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥12m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥28m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥2.1bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥690m |
| Nursing Servicereportable segment | capex | 2024-04-01 → 2025-03-31 | ¥40m |
| Nursing Servicereportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥77m |
| Nursing Servicereportable segment | employees | at 2025-03-31 | 714 pure |
| Nursing Servicereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥6.9bn |
| Nursing Servicereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥6.9bn |
| Nursing Servicereportable segment | segment assets | at 2025-03-31 | ¥1.5bn |
| Nursing Servicereportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥437m |
| Othersreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥55m |
| Othersreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥42m |
| Othersreportable segment | employees | at 2025-03-31 | 290 pure |
| Othersreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥3.0bn |
| Othersreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥3.0bn |
| Othersreportable segment | segment assets | at 2025-03-31 | ¥448m |
| Othersreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥773m |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥95m |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥118m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥9.9bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥9.9bn |
| —segment total | segment assets | at 2025-03-31 | ¥2.0bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥76m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥23m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥1.8bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥641m |
| Nursing Servicereportable segment | capex | 2023-04-01 → 2024-03-31 | ¥33m |
| Nursing Servicereportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥93m |
| Nursing Servicereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥6.9bn |
| Nursing Servicereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥6.9bn |
| Nursing Servicereportable segment | segment assets | at 2024-03-31 | ¥1.6bn |
| Nursing Servicereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥523m |
| Othersreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥37m |
| Othersreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥28m |
| Othersreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥2.7bn |
| Othersreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥2.7bn |
| Othersreportable segment | segment assets | at 2024-03-31 | ¥414m |
| Othersreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥637m |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥71m |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥120m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥9.6bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥9.6bn |
| —segment total | segment assets | at 2024-03-31 | ¥2.0bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Nursing Servicereportable segment | employees | at 2025-03-31 | 714 pure |
| Othersreportable segment | employees | at 2025-03-31 | 290 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,271
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 2500 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 4200000 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 37907 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 406800 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 406800 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0968 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 406800 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 406800 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0968 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 75863000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 20.00 | |
| Number of male directors and other officers | FilingDateInstant | 8 | |
| Number of female directors and other officers | FilingDateInstant | 0 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.00 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05440-000FukuharaToshioMember | 239 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05440-000FukuharaToshiharuMember | 545750 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05440-000KidakaTakafumiMember | 1230 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05440-000FujiyoshiMasaomiMember | 7209 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05440-000SonobeHiroshiMember | 8038 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05440-000AbeHiroshiMember | 2557 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05440-000HukumoriHisamiMember | 1105 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05440-000NaganumaToshiyukiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 566128 | |
| Audit fees reporting company | Prior1YearDuration | 26500000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 26500000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Audit fees total | Prior1YearDuration | 26500000 | JPY |
| Non audit fees total | Prior1YearDuration | － | JPY |
| Audit fees total | CurrentYearDuration | 26500000 | JPY |
| Non audit fees total | CurrentYearDuration | － | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 67875000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 67875000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | － | JPY |
| Retirement benefits remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 5 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 6000000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 6000000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Retirement benefits remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 1 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 13950000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 13950000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |